ANVLX | OAZIX | ANVLX / OAZIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 4 years | - |
Gain YTD | -0.325 | -4.929 | 7% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 559M | 16.9B | 3% |
Annual Yield % from dividends | 2.46 | 2.16 | 114% |
Returns for 1 year | -1.07 | 3.49 | -31% |
Returns for 3 years | -5.12 | -10.76 | 48% |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OIODX | 16.44 | -0.01 | -0.06% |
AXS Income Opportunities D | |||
MMLRX | 16.57 | -0.24 | -1.43% |
MassMutual Select TRP Large Cap Blend I | |||
SUHCX | 23.14 | -0.50 | -2.12% |
DWS Health and Wellness C | |||
TWRCX | 48.97 | -1.14 | -2.27% |
American Century Growth C | |||
FBTDX | 124.72 | -6.22 | -4.75% |
Franklin Biotechnology Discovery C |